COMMONWEALTH DIAGNOSTICS INTERNATIONAL, INC
Summary
gastrointestinal, Irritable Bowel Syndrome, hydrogen breath testing, methane breath testing, SIBO, diagnostic testing, CLIA-certified, diagnostic laboratory, malabsorption, functional gastrointestinal disorders, diarrhea, constipation, gas, testing, IBS, gastroenterology, digestive disorder
Industry
Profile
Address
Classification
Description
CDI is a GI health company providing industry leading diagnostic tests and tools to help physicians identify and diagnose common sources of digestive distress and functional gastrointestinal ailments. Focused on our patient-centric principles, our cost-effective portfolio of diagnostic products results in expedited treatment, better patient outcomes, and robust cost savings for the healthcare delivery system. Our portfolio includes: non-invasive at-home breath testing kits for Small Intestinal Bacterial Overgrowth (SIBO) and carbohydrate malabsorption disorders, as well as IBSchek, a proprietary capillary collection test for Irritable Bowel Syndrome (IBS-D/M), and MyTotalHealth, a cloud-based healthcare platform that enables patients to manage and understand their symptoms for a range of conditions. Operating out of our CLIA-certified clinical laboratory, we pride ourselves on our partnerships with some of the most preeminent health systems, hospitals, and private practices worldwide.
